Delivery Order SPE2DB20D1110-SPE2DB23FK38C
Award Date 9/1/23
Potential Completion Date 9/25/23
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,714.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561400686 INGREZZA 80 MG CAPSULE 30S. This order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Amerisourcebergen will deliver the specified medication from its facility in Conshohocken, Pennsylvania by July 25, 2023 to support DLA and DoD health programs. No set aside designation...
- The Defense Logistics Agency awarded a $3,119.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561786052 INGREZZA 40 MG CAPSULE 30S. This order was placed under an existing Prime Vendor contract vehicle to provide pharmaceutical products and services to DLA and DoD customers. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by September 1, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $11,028.36 delivery order to AmerisourceBergen Drug Corp for INGREZZA 40 MG capsules (30-count units) on August 25, 2025, with completion expected by September 16, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This delivery order for $3,714.98 was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation for the supply of 4562539054 INGREZZA 80 MG CAPSULE 30S. The place of performance is Conshohocken, Pennsylvania and the completion date is November 9, 2023. The contract type is firm fixed price with no set-aside designation. As the Defense Logistics Agency is responsible for worldwide logistics support of the U.S. Department of Defense, this order is likely to supply...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $15,600 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4562144466 INGREZZA 40 MG CAPSULE 30S to the agency. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, between September 12 and October 3, 2023. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the requested pharmaceutical products to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) with a contract ceiling value of $11,028.36. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for supply of INGREZZA 40 mg capsules (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical...
- This delivery order for $7,429.96 was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation for the provision of 4562494228 INGREZZA 80 MG CAPSULE 30S. The firm fixed price order has a period of performance through November 6, 2023. The place of performance is Conshohocken, Pennsylvania. No set-aside designation was applied to this order, which was issued against an existing vehicle held by Amerisourcebergen to supply pharmaceutical products to DLA in support of its...
- The Defense Logistics Agency awarded a $7,429.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562217300 INGREZZA 80 MG CAPSULE 30S. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the requested pharmaceutical products from its place of performance in Conshohocken, Pennsylvania under a schedule contract vehicle. The order period of performance spans from September 18, 2023 to October 10, 2023. As a component of the...
- The Defense Logistics Agency awarded a $6,239.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562087847 INGREZZA 40 MG CAPSULE 30S. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the requested pharmaceutical products from its place of performance in Conshohocken, Pennsylvania by September 28, 2023 in support of DLA programs. No set aside designation or subcontractors were identified. DLA manages the...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB23FK38CDelivery Order
The Defense Logistics Agency awarded a $16,364.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for INGREZZA 60 MG CAPSULE 30S. The order is being fulfilled under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Performance will take place in Conshohocken, Pennsylvania over a period of approximately four weeks concluding on September 25, 2023. Funding is provided by DLA in support of its medical logistics programs. No set aside designation or subcontractors are indicated for this order to supply the specified pharmaceutical product.
Generated 12/18/23, 10:34 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.4k | 9/1/23 |